v3.22.4
Reportable Segment and Major Customers Information - Consolidated Net Revenues (Detail) - Customer Concentration Risk [Member] - Revenues [Member]
3 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Two life science segment customers and its affiliates [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage 10.00%  
Customer A [Member] | Diagnostics [Member] | Segment Level [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage 7.00% 10.00%
Customer B [Member] | Diagnostics [Member] | Segment Level [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage 10.00% 11.00%
Customer C [Member] | Diagnostics [Member] | Segment Level [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage 12.00% 11.00%
Customer D [Member] | Life Science [Member] | Segment Level [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage   23.00%
Customer D [Member] | Life Science [Member] | Segment Level [Member] | Two life science segment customers and its affiliates [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage 0.00% 14.00%
Customer E [Member] | Life Science [Member] | Segment Level [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage 4.00% 14.00%
Customer F [Member] | Life Science [Member] | Segment Level [Member]    
Entity Wide Portfolio Carrying Amount, Major Customer [Line Items]    
Concentration percentage 12.00% 5.00%